文献速递细菌感染、耐药与抗菌药物

复发性Helicobacter cinaedi菌血症的危险因素及卡那霉素选择性消化道去污染预防复发的效果

Risk Factors for Recurrent Helicobacter cinaedi Bacteremia and the Efficacy of Selective Digestive Decontamination With Kanamycin to Prevent Recurrence.
PubMed 文献 · Clin Infect Dis · 2018-01-01

该回顾性研究纳入2009年3月至2016年12月日本2家医院168例Helicobacter cinaedi菌血症患者,34例复发,100天累积复发率为18.7%。多因素分析显示抗癌化疗(HR 2.47)和全身性类固醇(HR 2.40)为独立危险因素;选择性消化道去污染(SDD)可能降低复发率但未达统计学显著(HR 0.46,95%CI 0.18-1.18,P=.11),在比例风险建模分析中SDD降低复发率(HR 0.36,95%CI 0.13-1.00,P=.050)。

要点

  • H. cinaedi菌血症100天累积复发率为18.7%,抗癌化疗和全身性类固醇为独立危险因素。
  • SDD可能降低复发率但未达统计学显著(HR 0.46,95%CI 0.18-1.18,P=.11)。
  • 在比例风险建模分析中SDD降低复发率(HR 0.36,95%CI 0.13-1.00,P=.050)。

核心结论

  • H. cinaedi菌血症100天累积复发率为18.7%;抗癌化疗和全身性类固醇是复发的独立危险因素;SDD是降低复发的潜在策略。

研究设计与样本

  • 回顾性研究,纳入2009年3月至2016年12月日本2家医院168例H. cinaedi菌血症患者的病历资料。

主要发现

  • 168例中34例复发,100天累积复发率为18.7%。
  • 单因素分析显示抗癌化疗(HR 3.75,95%CI 1.86-7.58,P<.001)、全身性类固醇(HR 3.79,95%CI 1.70-8.45,P=.0011)和血液系统恶性肿瘤(HR 3.18,95%CI 1.64-6.19,P<.001)与复发相关。
  • 多因素分析显示抗癌化疗(HR 2.47,95%CI 1.19-5.12,P=.015)和全身性类固醇(HR 2.40,95%CI 1.03-5.61,P=.044)为独立危险因素。
  • 168例中47例接受SDD;Gray检验显示SDD可能降低复发率但未达统计学显著(HR 0.46,95%CI 0.18-1.18,P=.11)。
  • 在比例风险建模分析中,SDD降低复发率(HR 0.36,95%CI 0.13-1.00,P=.050)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Previous studies suggest that Helicobacter cinaedi can cause recurrent bacteremia. In this study, we elucidated the risk factors for recurrent H. cinaedi bacteremia and explored the efficacy of selective digestive decontamination (SDD) as a preventive measure. METHODS: We retrospectively reviewed the medical records of patients with H. cinaedi bacteremia between March 2009 and December 2016 at 2 Japanese hospitals. RESULTS: We identified 168 patients with H. cinaedi bacteremia. Bacteremia recurred in 34 patients. The 100-day cumulative incidence rate of recurrent bacteremia was 18.7%. In univariate analysis of factors associated with recurrent bacteremia, anticancer chemotherapy (hazard ratio [HR], 3.75; 95% confidence interval [CI], 1.86-7.58; P < .001), systemic steroids (HR, 3.79; 95% CI, 1.70-8.45; P = .0011), and hematological malignancy (HR, 3.18; 95% CI, 1.64-6.19; P < .001) were detected. Multivariate analysis indicated that anticancer chemotherapy (HR, 2.47; 95% CI, 1.19-5.12; P = .015) and systemic steroids (HR, 2.40; 95% CI, 1.03-5.61; P = .044) were the independent risk factors. Of the 168 patients, 47 received SDD. According to Gray's test, SDD might have reduced the rate of recurrence but this was not statistically significant (HR, 0.46; 95% CI, 0.18-1.18; P = .11). However, in a proportional hazard modeling analysis, SDD reduced the rate of recurrence (HR, 0.36; 95% CI, 0.13-1.00; P = .050). CONCLUSIONS: The 100-day cumulative incidence of recurrent H. cinaedi bacteremia was 18.7%. Anticancer chemotherapy and systemic steroids were independent risk factors for recurrent bacteremia. SDD is a potential strategy for reducing the recurrence.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Araoka H, Baba M, Okada C, et al. Risk Factors for Recurrent Helicobacter cinaedi Bacteremia and the Efficacy of Selective Digestive Decontamination With Kanamycin to Prevent Recurrence. Clin Infect Dis. 2018. PMID: 29462291. doi:10.1093/cid/ciy114

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。